Topical JAK Inhibitor Active in Itchy Prurigo Nodularis

[ad_1]

(MedPage Today) — ORLANDO — More than 40% of patients with longstanding prurigo nodularis (PN) had significant improvement within 3 months of starting topical ruxolitinib (Opzelura), according to a study reported here.
After 12 weeks of treatment…

[ad_2]

Source link : https://www.medpagetoday.com/meetingcoverage/aad/114594

Author :

Publish date : 2025-03-11 17:10:00

Copyright for syndicated content belongs to the linked Source.